New MGA Report on the Negative Economic Impact of Restricting Drug Rebates in Medicare Part D

New MGA Report on the Negative Economic Impact of Restricting Drug Rebates in Medicare Part D

Matrix Global Advisors (MGA) today released a new report, “Negative Economic Impact of Restricting Drug Rebates in Medicare Part D,” by MGA founder and CEO Alex Brill. The report looks at a July 2020 Executive Order on prescription drug rebates that invokes a proposed regulatory change President Trump withdrew a year earlier. The MGA report reviews the negative effects of the proposed rule documented at the time it was issued and presents new analyses related to drug rebates in Medicare Part D that have been released since. These analyses show that it would be impossible to fulfill the Executive Order’s mandate not to increase federal spending, Medicare beneficiary premiums, or patients’ total out-of-pocket costs.

For a PDF of the full report, click here.